Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;22(4):463-477.
doi: 10.1111/papr.13103. Epub 2022 Feb 25.

Management of chronic low back pain and the impact on patients' personal and professional lives: Results from an international patient survey

Brona Fullen  1   2 , Bart Morlion  2   3 , Steven J Linton  4 , David Roomes  5 , Joop van Griensven  6 , Lucy Abraham  7 , Craig Beck  7 , Stefan Wilhelm  8 , Cristina Constantinescu  9 , Serge Perrot  10
Affiliations

Management of chronic low back pain and the impact on patients' personal and professional lives: Results from an international patient survey

Brona Fullen et al. Pain Pract. 2022 Apr.

Abstract

Objective: The objective of this study was to investigate the impact of chronic low back pain (CLBP) on patients' personal and professional lives, and management strategies applied to treat CLBP.

Methods: A 60-question survey was developed, and respondents from 16 countries with a self-reported physician's diagnosis of CLBP were recruited via an online market research survey panel. Respondents were stratified as having mild, moderate, or severe pain. Target sample sizes per country and for pain severity were set. Data were weighted according to the known population and prevalence of CLBP in each country and the number of respondents from that country.

Results: Results from 9642 CLBP patients indicated that almost a quarter of patients with severe CLBP report a psychological comorbidity. Prescription pain medications were more commonly used by patients with severe CLBP (56%) than those with mild (20%) or moderate (34%) CLBP. Among those with severe CLBP who had been prescribed pain medication, 58% were prescribed opioids, with 1 in 4 patients using opioids for more than 5 years. Patients were primarily managed by general practitioners/primary care physicians, physiotherapists, neurologists, or orthopedic surgeons. CLBP negatively impacted patients' daily activities, social lives, and work productivity.

Conclusion: Chronic low back pain has pronounced effects on patients' personal relationships, ability to work, and daily living. Almost 1 in four patients with severe CLBP reported a psychological comorbidity. Adherence to guidelines appears inconsistent, which is noteworthy as a substantial subgroup of patients with severe CLBP had been prescribed opioid medication for more than 5 years. Improved education is required to support healthcare professionals (HCPs) in identifying and understanding the complex biopsychosocial needs of CLBP patients to optimize pain management and to encourage referral of CLBP patients to physiotherapists and psychologists.

Keywords: biopsychosocial model; chronic low back pain; international patient survey; pain management; psychological comorbidity.

PubMed Disclaimer

Conflict of interest statement

Bart Morlion and David Roomes have received grants for clinical research, consultancy activities, and speaker's activities from a number of pharmaceutical companies, including Pfizer Ltd and Eli Lilly and Company. Brona Fullen has received non‐restrictive educational grants and/or consultancy activities from pharmaceutical companies including Pfizer Ltd and Eli Lilly and Company. Joop van Griensven, Steven Linton, and Serge Perrot have received non‐restrictive grants for consultancy activities from Pfizer Ltd and Eli Lilly and Company. Craig Beck and Lucy Abraham are employees of Pfizer Ltd with stock and/or stock options. Stefan Wilhelm is an employee and shareholder of Eli Lilly and Company. Cristina Constantinescu is an employee of Ipsos SA, who were paid consultants to Pfizer Ltd and Eli Lilly and Company for this study and the development of this manuscript.

Figures

FIGURE 1
FIGURE 1
Design and results from screening survey
FIGURE 2
FIGURE 2
Effect on social life as a result of CLBP, split by CLBP severity. Percentages and weighted counts are shown of patients who agreed with the statements. To count as agreement, patients had to respond “strongly agree” or “somewhat agree.” CLBP, chronic low back pain
FIGURE 3
FIGURE 3
Patients’ agreement with positive and negative statements about work, according to the Stanford Presenteeism Scale. To count as agreement, patients had to respond “strongly agree” or “somewhat agree.” To count as disagreement, patients had to select “somewhat disagree” or “strongly disagree”
FIGURE 4
FIGURE 4
Percentages and weighted counts of patients who agreed with statements about feelings toward their work. To count as agreement, patients had to respond “strongly agree” or “somewhat agree”
See this image and copyright information in PMC

References

    1. Lodato EM, Kaplan W. Priority medicines for Europe and the world "a public health approach to innovation" update on the 2004 background paper. In: Kaplan W, Wirtz VJ, Mantel‐Teeuwisse A, Stolk P, Duthey B, Laing R, editors. Priority medicines for Europe and the world: 2013 updated background paper. Geneva: World Health Organization; 2013. p. 1–122.
    1. Global Burden of Disease Study 2013 Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. - PMC - PubMed
    1. Park TSW, Kuo A, Smith MT. Chronic low back pain: a mini‐review on pharmacological management and pathophysiological insights from clinical and pre‐clinical data. Inflammopharmacology. 2018;26:881–98. - PubMed
    1. Breivik H, Eisenberg E, O’Brien T. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health. 2013;13:1229. - PMC - PubMed
    1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333. - PubMed

Publication types